Violich Capital Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Violich Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$86.42 - $109.81 $8,642 - $10,981	-100 Reduced 0.93%	10,650 $1.12 Million
Q1 2021 Apr 30, 2021	SELL	$71.83 - $95.48 $161,617 - $214,830	-2,250 Reduced 17.31%	10,750 $989,000
Q4 2020 Jan 29, 2021	BUY	$67.0 - $84.39 $3,350 - $4,219	50 Added 0.39%	13,000 $951,000
Q1 2020 Apr 30, 2020	SELL	$24.87 - $38.56 $21,139 - $32,776	-850 Reduced 6.16%	12,950 $384,000
Q3 2019 Nov 06, 2019	SELL	$23.0 - $27.97 $11,500 - $13,985	-500 Reduced 3.5%	13,800 $376,000
Q2 2019 Jul 22, 2019	BUY	$22.81 - $28.48 $326,183 - $407,264	14,300 New	14,300 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Violich Capital Management, Inc. with notifications on news.